This article is a part of the “Navigating The 2023 VC Landscape,” which previously featured Mike Smerklo of Next Coast Ventures. Click here to view the previous installment, and follow Brian Penick on Forbes.com for more expert interviews with top investors and entrepreneurs.
For the next installment of this series, Brian Penick interviews Buffy Alegria, a venture capital and angel investor based in Yakima, WA. Her primary investment focuses on healthcare and companies that amplify women and other marginalized populations. Over the past few years, Buffy partnered to build one of the largest women’s health-focused venture funds, and she has invested in over 55 companies, 85% of which have female or minority founders. Some of Buffy’s notable investments include PregnanTech (a device for preventing pre preterm birth), OtoNexus (a device for reducing antibiotic use in the middle ear), and many others.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.